⚠ You're viewing a report from March 2021. Subscribe to get the latest →

FDA Enforcement — March 2021 Report

Automated analysis of 19 items from public government data sources. Updated daily.

Summary

19
Total items
8
High impact
11
Medium impact
0
Low impact

High-impact items this period

Fast Masks USA LLC
COVID-19 personal protective equipment adulterated and misbranded
Why: Masks marketed as COVID-19 protection without proper FDA authorization  ·  Mar 26  ·  Impact: HIGH
Bouji Moj Oyeeb, Inc. d/b/a MasterMix E-Liquid
Tobacco product adulteration and misbranding violations
Why: Non-compliance with Family Smoking Prevention and Tobacco Control Act requirements  ·  Mar 26  ·  Impact: HIGH
Ikcon Investments, Inc dba Ikcon Medical
COVID-19 medical devices adulterated and misbranded
Why: Unapproved COVID-19 medical devices marketed with false claims  ·  Mar 25  ·  Impact: HIGH
Tresmonet Technologies, Inc., TM Testing, Inc. dba TM Technologies, Inc./TM Labs
COVID-19 products adulterated and misbranded
Why: Unapproved COVID-19 testing or treatment products marketed improperly  ·  Mar 24  ·  Impact: HIGH
Distribuidora Lagunera del Norte S.A. de C.V.
Multiple violations: unapproved, misbranded, adulterated pharmaceuticals
Why: Marketed finished pharmaceuticals without approval with compliance defects  ·  Mar 23  ·  Impact: HIGH
Block Scientific
COVID-19 laboratory products adulterated and misbranded
Why: Unapproved COVID-19 testing products marketed improperly  ·  Mar 18  ·  Impact: HIGH
Shenzhen Weifa Technology Co., Ltd
Device IDE/PMA violation with adulterated device
Why: Distributing adulterated device without proper investigational or approval status  ·  Mar 11  ·  Impact: HIGH
maskshell.com
COVID-19 products adulterated and misbranded
Why: Selling unauthorized or misbranded COVID-19 related products online  ·  Mar 11  ·  Impact: HIGH

Selected medium-impact items

Immune & Genetics Protocols, LLC
New drug product misbranding and unauthorized marketing
Why: Product claims exceed allowable supplement health claims under FDA regulations  ·  Mar 30  ·  Impact: MEDIUM
George DeLallo Company, Inc.
Food product misbranding and labeling violations
Why: Inaccurate or inadequate product labeling and allergen declaration failures  ·  Mar 30  ·  Impact: MEDIUM
Hanover Foods Corporation
Food product misbranding and labeling violations
Why: Inaccurate or inadequate product labeling and allergen declaration failures  ·  Mar 26  ·  Impact: MEDIUM
Morin Enterprises Inc. d/b/a Ecig Crib
Tobacco products adulterated and misbranded
Why: Violated Tobacco Control Act through product composition and labeling  ·  Mar 26  ·  Impact: MEDIUM
Global Trade Bridge Corporation
Foreign Supplier Verification Program (FSVP) non-compliance
Why: Failed to implement adequate supplier verification procedures for imports  ·  Mar 25  ·  Impact: MEDIUM

Get this delivered every week

Free tier: 3 items per vertical. Full access with paid subscription.

Subscribe — $29/mo →

Data sourced from public government APIs. AI analysis via Claude Haiku. Full methodology →